Naya Biosciences, INC 8-K filings
8-K: INVO Bioscience Faces Funding Shortfall as NAYA Bioscience Fails to Meet Second Tranche Payment
INVO Bioscience is seeking alternative funding after NAYA Bioscience failed to deliver a $500,000 payment for preferred stock by the agreed deadline.